Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System
TAVR-HBE
1 other identifier
observational
409
1 country
1
Brief Summary
This is a prospective observational study, the purpose of which is to:
- 1.Characterize response of the AV conduction system to TAVR with various prostheses by recording continuous His bundle electrograms during valve placement.
- 2.Correlate preprocedure ECG features with changes in AV nodal and infranodal conduction during placement of the valve prosthesis.
- 3.Correlate changes in AV nodal and infranodal conduction during the procedure with risk of developing AV conduction block after TAVR.
- 4.Assess the contribution of stressing the conduction system by atrial pacing prior to and following TAVR to prediction of postprocedural heart block.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 18, 2021
CompletedFirst Submitted
Initial submission to the registry
July 20, 2021
CompletedFirst Posted
Study publicly available on registry
July 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 21, 2025
CompletedJanuary 24, 2025
January 1, 2025
2.7 years
July 20, 2021
January 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Heart block
We will prospectively follow patients for the development of heart block requiring permanent pacemaker implantation, and identify factors associated with heart block following TAVR..
30 days following procedure
Interventions
Transcatheter aortic valve replacement
Eligibility Criteria
Patients with severe aortic stenosis or regurgitation planned to undergo transcatheter aortic valve replacement
You may qualify if:
- patients undergoing elective TAVR at BIDMC
You may not qualify if:
- patients with permanent implanted pacemakers or ICDs prior to TA
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alfred Buxton
Boston, Massachusetts, 02215, United States
Related Publications (1)
Poulin MF, Ultimo B, Omar W, Rathakrishnan BG, Haouzi A, Pinto DS, Buxton AE, Laham RJ. Routine Electrophysiology Study During Transcatheter Aortic Valve Replacement: A Safety and Feasibility Pilot Study. JACC Cardiovasc Interv. 2023 Oct 23;16(20):2584-2586. doi: 10.1016/j.jcin.2023.07.017. Epub 2023 Sep 20. No abstract available.
PMID: 37737796RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alfred Buxton, MD
Beth Israel Deaconess Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Shlomo Ben-Haim, MD - Mark E. Josephson, MD, Professor of Medicine in Field of Cardiac Electrophysiology
Study Record Dates
First Submitted
July 20, 2021
First Posted
July 29, 2021
Study Start
May 18, 2021
Primary Completion
January 30, 2024
Study Completion
January 21, 2025
Last Updated
January 24, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
Global Results will be published, not individual patient data